If your dog scratches until they bleed, licks their paws raw, or wakes you up at 3 a.m. chewing their skin, you’ve probably already heard the word Apoquel. This guide covers exactly what it does, who should and shouldn’t take it, the real cancer question, how much it actually costs, and what to do when it stops working.
These are the questions dog owners type into search engines at midnight when the itching won’t stop and they’re not sure what to do. Here are honest answers, without the runaround.
Apoquel (oclacitinib maleate) is a prescription tablet that blocks a specific enzyme — JAK1 — that drives itch and allergic inflammation in dogs. It was FDA-approved in 2013 and is manufactured by Zoetis. Unlike antihistamines, which barely touch the itch signaling in dogs, Apoquel works at the cellular level. Most dogs notice significant relief within 4 hours of the first dose; full benefit typically appears within 24 hours. That speed is one reason it became one of the most-prescribed medications in veterinary medicine — when a dog is in misery, waiting days to see whether something is working is its own kind of problem.
The two-phase protocol is written into the FDA-approved label. The induction phase — twice daily for up to 14 days — is designed to bring active inflammation under control quickly. The maintenance phase — once daily afterward — is enough to keep symptoms from returning in most dogs once the flare is resolved. Using twice-daily dosing beyond 14 days is considered off-label by the FDA, though some veterinary dermatologists do recommend it for severe cases. If your dog is still struggling on once-daily dosing, that’s a conversation for your vet rather than a reason to quietly extend the twice-daily schedule yourself.
It happens, and it has more than one explanation. The most common is that your dog has developed a secondary skin infection — yeast or bacteria on top of the allergies — which prevents Apoquel from controlling the itch the way it should. If Apoquel is losing effectiveness, the first step is a recheck with your vet to rule out infection, not simply increasing the dose. Some dogs also develop new allergic sensitivities over time, meaning the triggers have expanded beyond what a single medication can manage. For dogs who genuinely seem to lose Apoquel’s effect without an infection present, a veterinary dermatologist — not just a general practice vet — is the right next step. They can run allergy testing and design a multi-layered plan.
This is the question that deserves the most careful answer. The FDA-approved label for Apoquel does contain an explicit warning: the drug may increase susceptibility to infection, including demodicosis, and exacerbation of neoplastic conditions. That means it can make a pre-existing cancer worse — which is why the label says dogs with a history of cancer should not use it. Whether Apoquel causes cancer in previously healthy dogs is a different question. A 2025 peer-reviewed pharmacovigilance study in the Journal of Veterinary Pharmacology and Therapeutics — which reviewed over a decade of post-market data — found no significant difference in cancer incidence between dogs treated with oclacitinib and dogs on other systemic allergy therapies. The current scientific consensus is that the drug does not appear to cause cancer in dogs who didn’t already have it, but it can accelerate cancer in dogs who do. A full exam and discussion of your dog’s health history before starting is not optional.
Apoquel does not require a formal taper the way steroids do — you won’t trigger a dangerous withdrawal syndrome by stopping it. However, stopping suddenly typically means the itch returns, sometimes within 24 to 48 hours, because Apoquel has a short half-life of about 4 hours. If you’re stopping because of a suspected side effect, call your vet before the next dose. If you’re stopping because it’s the end of allergy season, you can simply stop — though knowing that symptoms will likely return quickly is useful information so you’re not caught off guard.
For dogs with active cancer or a history of neoplasia, Apoquel is contraindicated — the FDA label is explicit. Even for dogs in remission, most veterinary oncologists and dermatologists prefer alternatives that don’t carry the neoplastic exacerbation risk. Cytopoint (lokivetmab) is generally the preferred alternative in this situation because it works through a completely different mechanism — a monoclonal antibody that neutralizes IL-31 rather than a drug that modulates the immune system broadly. Discuss this directly with your oncologist and dermatologist together if your dog has both an allergy and a cancer history.
Zenrelia (ilunocitinib) is a different JAK inhibitor approved by the FDA in September 2024, made by Elanco rather than Zoetis, with the same approved indication as Apoquel. It targets JAK1 more selectively than Apoquel does, which its developers suggest may mean a cleaner side-effect profile. The honest limitation: it lacks the decade-plus of real-world safety data that Apoquel now carries. That doesn’t mean it’s worse — it may prove to be better. But when a drug has been used in over 10 million dogs, the real-world evidence base is simply much larger. If your dog is currently doing well on Apoquel, switching for novelty alone is hard to justify. If Apoquel is failing or causing side effects, Zenrelia is a reasonable alternative to discuss with your vet.
Yes, and this is one thing many owners are never told clearly. Before starting, your vet should confirm there’s no underlying infection that would both prevent Apoquel from working and potentially be worsened by immune modulation. During long-term use — particularly for dogs on Apoquel year-round or on off-label twice-daily dosing — periodic blood panels (complete blood count and chemistry) are the standard of care. Apoquel can lower white blood cell counts and raise cholesterol and lipase levels; catching these changes early matters. If your dog has been on Apoquel for over six months and hasn’t had bloodwork reviewed recently, that’s the conversation to have at your next vet visit.
Understanding the basic mechanism helps you understand why it’s different from what came before, why it’s fast, and why the immune system concerns are real rather than theoretical.
Janus kinase 1, or JAK1, is an enzyme that acts as a relay switch inside immune cells. When your dog’s body encounters an allergen — pollen, dust mites, certain proteins in food — it triggers a chemical cascade. Cytokines including interleukin-31 (IL-31) bind to receptors on nerve cells and skin cells and signal: itch. JAK1 is a critical part of that signaling chain. Apoquel blocks JAK1, cutting the itch signal before it fully fires. Because the drug acts fast and targets a specific pathway rather than broadly suppressing the entire immune system the way steroids do, the onset is measured in hours, not days — and the side effects, while real, tend to be narrower than steroid side effects when used correctly.
Steroids (prednisone, dexamethasone) suppress the immune system so broadly that long-term use causes weight gain, increased thirst, muscle loss, and elevated liver enzymes at rates that make sustained use difficult. Antihistamines — Benadryl, cetirizine — block histamine receptors, but canine allergic itch is primarily driven by IL-31 and other cytokines, not histamine. That’s why antihistamines are largely ineffective for itchy dogs. Apoquel sits between these extremes: more targeted than a steroid, far more effective than an antihistamine, but not without immune-system implications of its own. It’s not a cure and it doesn’t treat the underlying allergy — it manages symptoms while the itch signals are active.
Apoquel is FDA-approved for two indications: control of pruritus (itching) associated with allergic dermatitis, and control of atopic dermatitis — both in dogs 12 months of age and older. It is sometimes used off-label for food allergy-associated itch and flea allergy dermatitis. It does not treat the underlying cause of the allergy. It does not cure skin infections — yeast and bacteria that develop alongside allergies still need separate treatment. It is not approved for cats, despite anecdotal use. And it will not work well if an active skin infection is present, because the infection maintains the itch signal independently.
The therapeutic window for Apoquel is narrower than most owners realize. Too low and it doesn’t work. Too high and the immune suppression becomes a problem. Here is the FDA-approved dosing protocol and tablet information, for reference — your veterinarian determines the actual dose for your specific dog.
Apoquel is a prescription medication. The dose below is the FDA-approved label dose for reference only. Your veterinarian calculates your dog’s specific dose based on weight, health status, and other factors. Do not adjust the dose, frequency, or duration without consulting your vet. Apoquel tablets are scored but should not be split by weight class — your vet will prescribe the appropriate tablet strength.
Induction phase: 0.4 to 0.6 mg of oclacitinib per kilogram of body weight (0.18 to 0.27 mg/lb), given twice daily by mouth for up to 14 days.
Maintenance phase: The same dose per administration, given once daily. There is no specified maximum duration for maintenance therapy in the FDA label — dogs can remain on once-daily dosing long-term with appropriate veterinary monitoring.
Can be given with or without food. Giving it with a small amount of food may reduce the chance of mild stomach upset in sensitive dogs.
| Tablet Strength | Marked | Typical Dog Weight Range | Notes |
|---|---|---|---|
| 3.6 mg | AQ-S (Small) | 3.0 – 5.9 kg (6.6 – 13 lbs) | Smallest dogs; very precise dosing needed |
| 5.4 mg | AQ-M (Medium) | 6.0 – 9.9 kg (13 – 22 lbs) | Medium-small dogs; most common size in first range |
| 16 mg | AQ-L (Large) | 10.0 kg and up (22 lbs+) | Large dogs; half-tablet sometimes used for mid-range weights per vet guidance |
Give the missed dose as soon as you remember, unless it is almost time for the next scheduled dose — in that case, skip the missed dose and continue with the regular schedule. Never give two doses at once to make up for a missed one. Because Apoquel has a short half-life of roughly 4 hours, skipping a dose will typically mean the itch starts returning within 24 hours, but this is not dangerous — it’s just uncomfortable for your dog.
Apoquel’s side effects fall into two categories: the common and mostly mild ones seen in clinical trials, and the less common but more serious ones that have appeared in post-approval surveillance reports to the FDA. Both matter, and neither should come as a surprise.
During the pre-approval field study (Days 0–16), the adverse reactions reported in dogs receiving Apoquel at approximately therapeutic rates included:
- Diarrhea: 4.6% of Apoquel dogs vs. 3.4% on placebo — modest and often resolved without stopping the drug
- Vomiting: 3.9% vs. 4.1% on placebo — not significantly different from placebo in this period
- Anorexia (reduced appetite): 2.6% vs. 0% on placebo — more notable, worth monitoring in dogs already inclined to skip meals
- New skin or subcutaneous lump: 2.6% vs. 2.7% placebo — not meaningfully different
- Lethargy: 2.0% vs. 1.4% on placebo — mild difference
Lab changes: dogs on Apoquel showed decreased white blood cell counts (neutrophils, eosinophils, monocytes), decreased globulins, and increased cholesterol and lipase compared to placebo. These are the numbers that make routine bloodwork during long-term use non-optional.
The FDA’s post-approval adverse drug experience reports — submitted by veterinarians and owners — have included the following, in decreasing order of reporting frequency. Note: these are reported associations, not proven causes.
- Vomiting and lethargy — most frequently reported, consistent with pre-approval data
- Elevated liver enzymes — reason for periodic liver panel monitoring
- Dermatitis — crusts, pododermatitis (paw inflammation), pyoderma (skin infection)
- Seizures — reported; causality not established; report any new seizure activity to your vet immediately
- Polydipsia — excessive thirst; also seen with other allergy medications
- Demodicosis — demodex mite overgrowth due to immune modulation; watch for hair loss and skin thickening
- Benign and malignant neoplasms — including papillomas, histiocytomas, lymphoma; see the cancer section of this guide
- Death (including euthanasia) — reported; the nature of the cases makes causality very difficult to establish
- New lumps or bumps that weren’t there before, especially ones that grow quickly
- Significant hair loss with scaling or crusting (possible demodex)
- Any seizure or sudden neurological change
- Signs of serious infection: fever, swelling, wound that won’t heal
- Sudden complete loss of appetite lasting more than 24 hours
- Extreme lethargy — can’t or won’t get up, no interest in surroundings
This is the topic that sends owners searching at midnight. It deserves a genuinely careful answer — not reassurance that glosses over the label warning, and not alarm that overstates the evidence against the drug.
The FDA-approved label for Apoquel includes this precaution: “APOQUEL may increase susceptibility to infection, including demodicosis, and exacerbation of neoplastic conditions.” Under the post-approval experience section, the label lists benign tumors, malignant tumors, lymphoma and other cancers as reported events. The label also instructs that Apoquel is not for use in dogs with serious infections, and that the drug modulates the immune system.
A 2025 peer-reviewed pharmacovigilance study published in the Journal of Veterinary Pharmacology and Therapeutics — the most comprehensive safety review of Apoquel to date, covering pre-approval and more than a decade of post-market data — found that an age- and breed-matched retrospective cohort study showed no significant difference in cancer incidence between dogs treated with oclacitinib and dogs treated with other systemic allergy therapies.
Additionally, a 2026 review in Today’s Veterinary Practice noted that many online reports attributing cancer to Apoquel likely reflect dogs whose skin signs were early symptoms of an internal disease — including cancer — that had not yet been diagnosed when Apoquel was started. The drug may have been blamed for a process that was already underway before the first tablet.
The current evidence does not show that Apoquel causes cancer in dogs who were otherwise healthy when they started it. The evidence does show that immune modulation can accelerate the growth of existing cancers. Those two statements are both true at the same time, and holding both is the accurate position. Dogs with any history of cancer, active infections, or known immune system conditions should not use Apoquel. Dogs without those risk factors, used at the right dose with periodic monitoring, face a risk profile that most veterinary dermatologists consider acceptable relative to the benefit of stopping severe allergic itch.
There is no FDA-approved generic oclacitinib in the United States. Apoquel is manufactured exclusively by Zoetis. The cost is real, ongoing, and for large dogs on year-round dosing, can be significant.
| Tablet | Approx. per tablet | 30-day cost (once daily) | Notes |
|---|---|---|---|
| 3.6 mg (small dogs) | ~$2.50–$3.00 | $75–$90/month | Small breed; lower monthly total |
| 5.4 mg (medium dogs) | ~$2.60–$3.10 | $78–$93/month | Similar pricing across strengths |
| 16 mg (large dogs) | ~$2.75–$3.25 | $83–$98/month | Larger dogs may need 1.5–2 tablets; costs rise |
| Very large dogs (2 tablets) | ~$5.50–$6.50/day | $165–$195/month | Dogs over ~60 lbs needing 2× 16 mg |
- Compare pharmacies: Chewy Pharmacy, Costco Pharmacy, PetMeds, and Tractor Supply often price Apoquel 5–15% lower than in-clinic dispensing. Ask your vet for a written prescription you can fill elsewhere.
- Autoship programs: Chewy and PetMeds typically offer 5–10% off with autoship, which compounds meaningfully over a year of daily use.
- Seasonal cycling: Dogs with strictly seasonal allergies (spring pollen, fall ragweed) may not need year-round dosing. Ask your vet whether starting Apoquel at the beginning of allergy season and stopping after it ends is appropriate for your dog — some dogs manage 3–4 months per year rather than 12.
- Zoetis patient assistance: Zoetis periodically offers rebate programs and savings cards. Ask your vet’s office or check zoetispetcare.com — availability varies.
- Discuss alternatives: Cytopoint injections (once every 4–8 weeks at the vet) may work out cheaper per year for smaller dogs. See the comparison section below.
These two treatments dominate the canine allergy market. They work differently, suit different situations, and have genuinely different risk profiles. Neither is universally better — the right answer depends on your specific dog.
| Factor | Apoquel (oclacitinib) | Cytopoint (lokivetmab) |
|---|---|---|
| Type | Small molecule JAK1 inhibitor tablet | Monoclonal antibody injection |
| How given | Pill by mouth at home daily | Injection at vet clinic every 4–8 weeks |
| How fast | Itch relief within 4 hours | Itch relief within 24 hours |
| Duration | Lasts about 24 hours; must be given daily | Lasts 4–8 weeks per injection |
| Cancer history | Contraindicated — avoid | Generally preferred alternative |
| Puppies under 12 mo | Not approved | Approved from 12 weeks of age |
| Immune suppression risk | Moderate — JAK pathway immune modulation | Lower — targets only IL-31 pathway |
| Cost — small dog | ~$75–$90/month (once daily) | ~$50–$90/injection; $25–$45/month amortized at 8-wk interval |
| Cost — large dog | ~$85–$100/month (once daily) | ~$120–$220/injection; may exceed $400–$500/yr if needed every 4 wks |
| Missed dose consequence | Itch may return in 24 hrs | No daily compliance needed |
| Real-world safety data | 10+ years; 10M+ dogs | Since 2016; several million dogs |
| Blood work monitoring | Recommended for long-term use | Not routinely required |
- Large dogs — the daily pill is almost always cheaper per year than monthly injections at scale
- When fast relief is needed and a vet visit isn’t convenient at that moment
- Dogs who need precise dose adjustments — the pill gives more flexibility than a pre-filled injection
- Dogs who respond extremely well and have been stable on once-daily dosing for years
- Any dog with a cancer history or current cancer diagnosis
- Dogs who hate taking pills and spit them out despite all tricks
- Small dogs whose annual Cytopoint cost (at 8-week intervals) beats daily Apoquel
- Owners who prefer not to manage daily dosing compliance
- Younger dogs (Cytopoint is approved from 12 weeks; Apoquel requires 12 months)
Call your vet today and ask for an urgent appointment. While you wait, an Elizabethan collar (cone) can prevent your dog from worsening the damage and setting up a skin infection in an open wound. Don’t start someone else’s prescription Apoquel — the dose, any underlying infection status, and your dog’s health history all need to be verified first. If your dog has been on Apoquel before and your vet has refills available, call the office and ask about restarting — many practices can reauthorize a refill with a quick consultation call rather than a full visit, especially for an established patient.
This is very common and worth raising directly with your vet. Ask for a complete blood count and chemistry panel — these are the tests that can catch the white blood cell decreases, cholesterol elevations, and liver enzyme changes that Apoquel can cause over time. If your dog is on twice-daily Apoquel long-term rather than once-daily, this monitoring is even more important. Bring up the question at your next visit or call the clinic to ask whether monitoring bloodwork is overdue. Most vets appreciate the question and will agree that it’s time.
The most likely culprit is a secondary skin infection — yeast or bacteria — that has developed alongside the allergies and is now sustaining the itch signal independently of the underlying allergy. A vet visit for a skin cytology (looking at cells from the skin under a microscope) is the first step — it takes minutes in the clinic and can confirm or rule out infection. If infection is present, treating it often restores Apoquel’s effectiveness without any change in dose. If there’s no infection and Apoquel genuinely appears to be losing effect, your dog may have developed new sensitivities that have expanded beyond what Apoquel can manage alone. A referral to a board-certified veterinary dermatologist is appropriate at that point.
Before stopping suddenly, call your vet and say exactly that. Options to discuss: comparing pharmacy prices (Chewy, Costco, PetMeds often beat in-clinic prices by 10–20%); switching to Cytopoint if your dog is smaller and the injection interval can be stretched to 6–8 weeks; seasonal dosing if your dog’s allergies have a defined season; or a dermatology consultation to identify whether allergen-specific immunotherapy (allergy shots built around your dog’s specific triggers) could reduce or eliminate the need for daily medication over time. Allergen immunotherapy has a higher upfront cost but has the potential to significantly reduce long-term medication dependence — it’s the only option that treats the underlying allergy rather than the symptoms.
Stop Apoquel and contact your veterinarian and a veterinary oncologist today. Do not wait for the next scheduled appointment. The FDA label is explicit that Apoquel may exacerbate neoplastic conditions, meaning it can potentially accelerate tumor growth. Your oncologist and vet will need to review the full picture — cancer type, stage, current medications — and can recommend an alternative for allergy management if needed, most commonly Cytopoint, which does not carry the same immune-modulation risk profile.
Probably one thing: confirming that routine monitoring is in place. If your dog is stable on once-daily Apoquel with no concerning symptoms, that’s genuinely good news — Zoetis’s own data shows 60% of moderate-to-severe atopic dogs are controlled long-term at maintenance dosing. The one thing most owners on stable, long-term Apoquel underutilize is periodic bloodwork — a CBC and chemistry panel once or twice a year. It adds modest cost but gives you a baseline to compare against if something does shift. Also: do a full-body physical check at home every few weeks, running your hands over your dog and looking for any new lumps, bumps, or skin changes. Catching anything new early is the most valuable thing you can do for a dog on a long-term immunomodulating drug.
For dogs on once-daily maintenance Apoquel, most veterinary dermatologists recommend a complete blood count and full chemistry panel at least annually — more frequently for dogs on off-label twice-daily dosing, seniors, or dogs with any pre-existing organ concerns. The CBC tracks white blood cell counts (which Apoquel can lower) and platelet levels. The chemistry panel catches cholesterol, lipase, and liver enzyme changes. If your vet hasn’t suggested this and your dog has been on Apoquel for over six months, raise it directly.
Every few weeks, run your hands slowly over your dog’s entire body. You are looking for any new lumps, bumps, or thickened skin patches that weren’t there before. Pay particular attention to lymph node locations — under the jaw, in front of the shoulders, in the armpits, groin, and behind the knees. Enlarged lymph nodes can be a sign of infection or, less commonly, lymphoma. Also watch for: patches of hair loss with scaling (possible demodex), skin wounds that aren’t healing normally, or any signs your dog is drinking significantly more water than usual. None of these are certainties — but they are reasons to call the vet rather than wait for the next scheduled visit.
Not every dog needs Apoquel 365 days a year, even if that’s how it started. Dogs with clearly seasonal allergies — symptoms that reliably appear in spring and disappear in fall, for example — may be candidates for cyclic use: starting Apoquel at the onset of their season and stopping when symptoms resolve. This reduces cumulative immune exposure and annual cost meaningfully. If you’ve never had this conversation with your vet, bring it up at the next visit — “Is my dog a candidate for seasonal dosing rather than year-round?” is a completely reasonable question. The answer depends on how reliable the seasonal pattern is and whether your dog has any year-round triggers.
A board-certified veterinary dermatologist (DACVD) is the appropriate specialist for dogs who have been on allergy medication for more than a year without clear resolution of symptoms, dogs who have required repeated doses of antibiotics or antifungals for recurrent infections, dogs in whom Apoquel is failing or needs to be stopped, and dogs whose itch is severe enough to affect quality of life despite multiple medication trials. Dermatologists can perform allergy testing (intradermal skin testing or serum testing) and design allergen-specific immunotherapy — the only currently available treatment that targets the underlying allergy rather than masking the symptoms. The upfront cost is higher; the potential long-term benefit is significant. Find a board-certified veterinary dermatologist through the American College of Veterinary Dermatology at acvd.org.
This guide is for general informational purposes only and does not constitute veterinary medical advice. Apoquel (oclacitinib maleate) is an FDA-approved prescription veterinary medication; it requires a valid veterinarian-client-patient relationship and a prescription before dispensing. All dosing information is provided for educational reference and reflects the FDA-approved label — your veterinarian determines the appropriate dose, frequency, and duration for your specific dog based on their individual health profile. The cancer risk information reflects published evidence as of the date of this writing; research in this area is ongoing and recommendations may evolve. Do not start, stop, or adjust Apoquel without consulting your veterinarian. Report adverse events to FDA at 1-888-FDA-VETS or fda.gov/reportproblem. This content is entirely original and was independently written for educational purposes.
Featured image: Photo by rzierik on Pixabay · Pixabay Content License
I had my Louie on Apoquel for years because he would not stop scratching and chewing himself. Started Louie on Natures Blend by Dr Marty and after a week decided to take him off of apoquel and it worked. He doesn’t have that bad itch anymore. I spend 92.00 on Dr Marty dog food that last me a month & a half compared to 85.00 a month on Apoquel. Louie is 25lbs and eats a hand full every day. Also doesn’t have bad breath anymore. I even buy freeze dried treats for him. I do though give him a small packet of Cesars filets in gravy every morning after his walk, a small breakfast which he loves.